Research On The Counter-measure For Detection And Prevention Of Commercial Bribery In Pharmaceutical Sales Area

In recent years, the area of pharmaceutical sales, the hardest hit of commercial bribery, has been identified as one of the key governing areas. As part of public services, medical institutions representing government image should be a people-based link between the government and people. That commercial bribery in pharmaceutical sales area dominates in society, however, not only increases the economic burden of patients, but also deteriorates in the doctor-patient relationship, which distorts the social justice, undermines the social stability, and also stains the government's credibility and public image. For the baneful influence in this area, control is of greatly urgency. We must adhere to combine ban with mediation, to combine punishment with prevention. At the same time building time-leased prevention and control system of commercial bribery. From the perspective of investigation, this paper discusses the counter-measure for detection and prevention of commercial bribery in pharmaceutical sales area and the foundation of a timed-release detection and prevention system.Besides the introduction, this paper divides into three parts, whose mainbody has about 30,004 words.The first part is the overview of commercial bribery in pharmaceutical sales area. This part begins with the origin of commercial bribery, briefly discourses its development in China, and then dissects its concept in narrow and broad senses to determine the keynote of commercial bribery in broader context, and to give definition of commercial bribery in n pharmaceutical sales area, i.e. , in medical sales and health services operators bribe other units and individuals, provide or accept profit-generating services in order to sell or purchase medical-lies; operators and other units or individuals against their authorities request or accept bribery to give favors to bribers; operators introduce bribe to related governors, all of which break criminal laws and should be punished. Finally, combining with the current condition, this part analyze the harm which are leading to a virtual high medicine price and increasing the burden on patients, degrading medical ethics and fraying the relation between doctors and patients, damaging the image of the medical industry and declining government credibility, making a huge loss of state assets and affect international image negatively.Part two discourses the features and detection in commercial bribery in pharmaceutical sales area. First, it analyzes bribery crime's features in this area laying the foundation of the research on counter-measures of defection. The bribery crime in this area has the following features, i.e., chronic crime, uncertain scenes, multi-organizer, strong sense of anti-detection, diversifying means, serious consequences, large sum involved and so on. Second, according to the features of commercial bribery criminal cases in pharmaceutical sales area, the part explores the investigative strategies. As limited sources of clues in this field, strong resistance of investigation, the particularity of commercial bribery in pharmaceutical sales area, lack of law, and unappeasable investigative techniques, it makes considerable difficulties on the investigation of commercial bribery cases in commercial bribery in pharmaceutical sales area. It's of particular importance to make breakthroughs in times of hardship and starting with people and events as relevant evidence to find out the breach in investigation of commercial bribery in the field of medicine purchase and sale. Based on the right choice of the breach and comprehensive analysis of case materials, we'll bring out investigation measures to crack down on commercial bribery medicine purchase and sale form both macro and micro angles, such as the expansion of multi-level sources of clues, in the exercise of ordinary investigative techniques at the same time of the integration of special investigative techniques and the use of a variety of other means of identification.The third part is about the reasons and foundation of detection and prevention system. In this part, it will at first comprehensive practical factors and work out the main reasons for the popularity of commercial bribery in the pharmaceutical purchasing field, which are, the hospital's "double" monopoly status, drugs to support medical and other unreasonable medical system, the lack of supervision and punishment lax regulatory loopholes and the absence of such laws. Then it will give suggestions on constructing the Medicine Control System of Commercial Bribery form multi-levels and angles, targeted from the health care reform, and strengthen internal and external supervision, improve relevant laws and strengthening public education, etc.